Cargando…
KIAA0101 is associated with human renal cell carcinoma proliferation and migration induced by erythropoietin
Erythropoietin (EPO) is a frequently prescribed anti-anemic drug for patients with advanced renal carcinoma. However, recent evidence from clinical studies suggested that EPO accelerated tumor progression and jeopardized the 5-year survival. Herein, we show, starting from the in silico microarray bi...
Autores principales: | Fan, Shengjun, Li, Xin, Tie, Lu, Pan, Yan, Li, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924658/ https://www.ncbi.nlm.nih.gov/pubmed/26575329 http://dx.doi.org/10.18632/oncotarget.5876 |
Ejemplares similares
-
KIAA0101 Is Overexpressed, and Promotes Growth and Invasion in Adrenal Cancer
por: Jain, Meenu, et al.
Publicado: (2011) -
KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma
por: Guo, Minglei, et al.
Publicado: (2006) -
Increased KIAA0101 gene expression associated with poor prognosis in breast cancer
por: Liu, Jiuyang, et al.
Publicado: (2021) -
Overexpression of KIAA0101 Promotes the Progression of Non-small Cell Lung Cancer
por: Cao, He, et al.
Publicado: (2020) -
Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary Tumors
por: Roche, Magali, et al.
Publicado: (2015)